Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: povidone; pregelatinised maize starch; croscarmellose sodium; maize starch; potassium sorbate; microcrystalline cellulose; stearic acid; magnesium stearate; purified talc - comfarol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - codeine phosphate hemihydrate, quantity: 15 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; lactose monohydrate; docusate sodium; povidone; potato starch - for the relief of acute moderate pain and fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: stearic acid; maize starch; pregelatinised maize starch; povidone; magnesium stearate; purified talc; croscarmellose sodium; potassium sorbate; microcrystalline cellulose - prodeine forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - paracetamol, quantity: 500 mg; codeine phosphate hemihydrate, quantity: 30 mg - tablet, uncoated - excipient ingredients: potassium sorbate; maize starch; povidone; purified talc; stearic acid; magnesium stearate; microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch - panadeine forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 8 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: soluble maize starch; povidone; microcrystalline cellulose; stearic acid; potassium sorbate; magnesium stearate; maize starch; purified talc - for the relief of acute moderate pain

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 9.75 mg; doxylamine succinate, quantity: 5 mg; paracetamol, quantity: 450 mg - tablet, uncoated - excipient ingredients: magnesium stearate; purified talc; microcrystalline cellulose; sodium starch glycollate; quinoline yellow; sunset yellow fcf; stearic acid; povidone; pregelatinised maize starch; crospovidone - for the relief of acute moderate pain and fever

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: purified talc; pregelatinised maize starch; stearic acid; maize starch; povidone; potassium sorbate - relief of pain and discomfort in arthritis, headahce, muscular and neuralgic conditions. reduced fever. panamax is useful as an analgesic for patients with dyspepsia, ulcers or gout.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - doxylamine succinate, quantity: 5 mg; codeine phosphate hemihydrate, quantity: 9.75 mg; paracetamol, quantity: 450 mg - tablet, uncoated - excipient ingredients: quinoline yellow; sodium starch glycollate; sunset yellow fcf; purified talc; magnesium stearate; microcrystalline cellulose; stearic acid; povidone; pregelatinised maize starch; crospovidone - for the relief of acute moderate pain and fever

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 450 mg; doxylamine succinate, quantity: 5 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; magnesium stearate; purified talc; stearic acid; povidone; pregelatinised maize starch; crospovidone - indications as at 9 june 2020: mersyndol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 450 mg; codeine phosphate hemihydrate, quantity: 30 mg; doxylamine succinate, quantity: 5 mg - tablet, uncoated - excipient ingredients: purified talc; microcrystalline cellulose; magnesium stearate; sodium starch glycollate; hypromellose - mevadol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.